Breast and Gynecologic Cancer

The Breast and Gynecologic Cancer Research Group (BGCRG) conducts and fosters the development of research on the prevention and early detection of breast cancer, cervix and human papillomavirus (HPV)-related cancers, endometrial cancers, ovarian cancers, and precursor conditions related to these cancers.

Read more About the Breast and Gynecologic Cancer Research Group.

Staff

Funding Opportunities

Grants

Clinical Trials

Publications

Cancer Prevention Clinical Trials Network (CP-CTNet)

A medical professional shakes hands with a patient seated on a examination table.

Research Centers develop and conduct early phase clinical trials to assess the preventive potential of agents and interventions of varying classes.

HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network

Seeks to conduct pragmatic clinical trials evaluating the effectiveness of clinically proven interventions to optimize the cervical cancer screening, management, and precancer treatment cascade for WLWH.

The National Cancer Institute (NCI)’s Cervical Cancer ‘Last Mile’ Initiative

The 'Last Mile'  is a public-private partnership bringing together federal agencies, industry partners, and professional societies to contribute evidence about the accuracy and clinical effectiveness of self-sampling-based HPV testing for cervical cancer screening.

US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)

Partnership Centers will focus on improving prevention of human papillomavirus (HPV)-related cancers in human immunodeficiency virus (HIV)-infected individuals.

News and Events

Methods and Techniques for Clinical and Preclinical Chemotherapy-induced Peripheral Neuropathy (CIPN) Research
Date Posted: June 18, 2024

ULACNet Update - April 2024
Date Posted: April 25, 2024

Fatigue in Pediatric Cancer Populations
Date Posted: March 26, 2024

DCP Participation at American Association for Cancer Research (AACR) Annual Meeting, April 5-10, 2024
Date Posted: March 12, 2024

The Role of Neoantigen-Specific T-Cells in Cancer Interception and Immune Monitoring of Lynch Syndrome
Date Posted: February 22, 2024